{
  "schema_version": "0.1.0",
  "case_id": "HR-ML013",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML013",
    "display_name": "Arthur Ashe",
    "aliases": [
      "Arthur Robert Ashe Jr."
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1943-07-10",
          "display": "July 10, 1943",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1943",
              "display": "1943",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with Encyclopedia Virginia."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1993-02-06",
          "display": "February 6, 1993",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1993",
              "display": "1993",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML013-SYN",
      "ssn": "000-13-6620",
      "date_of_birth": "1980-07-10",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Vivian Tolliver, MD",
      "fictional_consultant": {
        "name": "Priyanka Rao, MD",
        "specialty": "Infectious Diseases"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1943-07-10",
        "display": "July 10, 1943",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Richmond, Virginia.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1979-07-31",
        "display": "July 31, 1979",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Heart attack while teaching tennis to young people.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1979",
        "display": "1979",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Quadruple coronary artery bypass surgery.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1983",
        "display": "1983",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Second (double) bypass operation, with a blood transfusion.",
      "claim_ids": [
        "CLM-0003",
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1988",
        "display": "1988",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Brain surgery for a mass found to be toxoplasmosis; HIV diagnosed.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1992-04-08",
        "display": "April 8, 1992",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Announced publicly that he had HIV.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1993-02-06",
        "display": "February 6, 1993",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in New York City.",
      "claim_ids": [
        "CLM-0008"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Arthur Robert Ashe Jr. was born in Richmond, Virginia, on July 10, 1943, to Mattie Cunningham Ashe and Arthur Robert Ashe Sr.; his mother died before he was seven.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "On July 31, 1979, while teaching tennis to inner-city youth, Ashe had a heart attack, and he then underwent quadruple coronary artery bypass surgery in 1979.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the synthetic coronary artery disease and old myocardial infarction. One source dates a first heart attack to July 1976; the 1979 date is preferred (see sources.md).",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "quadruple bypass operation in 1979"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "disputes",
          "locator": "dates his first heart attack to July 1976"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "When chest pain recurred, Ashe had a second bypass operation, a double bypass, in 1983, during which he received a blood transfusion.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for two bypass operations.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "double bypass graft, in 1983"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In 1988 Ashe had difficulty moving his right hand and arm; a scan showed a mass in the left side of his brain, which surgeons removed, and the diagnosis was toxoplasmosis. Testing then showed that he had HIV and AIDS.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the synthetic HIV disease with a history of cerebral toxoplasmosis. The month of the operation was not verified in a fetched source.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "emergency brain surgery after experiencing paralysis of his right arm"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0005",
      "statement": "Ashe and his doctors concluded that he had almost certainly acquired HIV from a blood transfusion during his 1983 heart operation, before blood was tested for the virus.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documents the route of acquisition; the modern frame keeps it as history only (see sources.md).",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "Ashe kept his diagnosis private at first, telling only a few family members and friends. On April 8, 1992, after learning that USA Today planned to report it, he announced at a press conference that he had HIV.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the true-frame index date; recorded in the timeline. Supports the episode's emphasis on his control over disclosure.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Both of Ashe's parents had atherosclerotic heart disease at early ages. His mother died at 27 of complications from surgery, and his father had two heart attacks, at 55 and at 59.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Family history of early coronary disease.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "Ashe died in New York City on February 6, 1993, aged 49, of AIDS-related pneumonia. His memoir, Days of Grace, was published after his death.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Recorded as a fact without detail; after the episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Arthur Ashe (1943-1993)",
      "publisher": "Encyclopedia Virginia (Virginia Humanities)",
      "url": "https://encyclopediavirginia.org/entries/ashe-arthur-1943-1993/",
      "source_type": "scholarly",
      "published": "2020-12-07",
      "accessed": "2026-11-03",
      "rights_note": "Encyclopedia article by Boyd Childress; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Lerner BH. Arthur Ashe and AIDS: Did the public have the right to know his diagnosis?",
      "publisher": "STAT",
      "url": "https://www.statnews.com/2022/06/26/arthur-ashe-and-aids-did-the-public-have-the-right-to-know-his-diagnosis/",
      "source_type": "scholarly",
      "published": "2022-06-26",
      "accessed": "2026-11-03",
      "rights_note": "Opinion essay by a physician and medical historian; facts used with citation, no quotations."
    },
    {
      "source_id": "SRC-0003",
      "title": "Markel H. Arthur Ashe's other great serve: as activist for health",
      "publisher": "PBS NewsHour",
      "url": "https://www.pbs.org/newshour/health/arthur-ashes-other-great-serve-as-activist-for-health",
      "source_type": "scholarly",
      "published": "2021-07-10",
      "accessed": "2026-11-03",
      "rights_note": "Essay by a physician and medical historian; facts used with citation, no quotations."
    },
    {
      "source_id": "SRC-0004",
      "title": "Arthur Ashe",
      "publisher": "Biography.com (A&E Television Networks)",
      "url": "https://www.biography.com/athletes/arthur-ashe",
      "source_type": "other",
      "published": "2014-04-02",
      "accessed": "2026-11-03",
      "rights_note": "Reference biography, last updated November 16, 2021; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-03",
      "accessed": "2026-11-03",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-01-12",
    "index_age": 45,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Person-first, confidential primary care for a 45-year-old man four months after HIV was diagnosed with cerebral toxoplasmosis, who also has coronary artery disease after two bypass operations: viral load and CD4 monitoring on bictegravir, emtricitabine, and tenofovir alafenamide (an antiretroviral regimen chosen to avoid interactions with his statin and cardiac medicines and to avoid abacavir), trimethoprim-sulfamethoxazole maintenance and its safe discontinuation by CD4 count, vaccines for adults with HIV, and secondary prevention of coronary disease to an LDL goal below 55 mg/dL, on the DHHS and IAS-USA antiretroviral guidance, the DHHS opportunistic infection guidelines, the HIVMA/IDSA primary care guidance, and the CMID ischemic heart disease and hyperlipidemia monographs.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-01-12",
        "purpose": "Establishing primary care for HIV after a recent diagnosis with cerebral toxoplasmosis, and for coronary artery disease after two bypass operations"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-02-09",
        "purpose": "Four-week check of potassium and creatinine, second hepatitis B vaccine, and infectious diseases consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-13",
        "purpose": "Three-month HIV and lipid review"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-07-13",
        "purpose": "Six-month HIV and coronary disease review with depression screening"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-08-17",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-19",
        "purpose": "Nine-month HIV review: decision to stop toxoplasmosis maintenance therapy"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infection",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B20",
            "display": "Human immunodeficiency virus [HIV] disease",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented HIV infection and AIDS diagnosis; B20 stays the code after an AIDS-defining illness, however well the infection is controlled.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapy",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B58.2",
            "display": "Toxoplasma meningoencephalitis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented 1988 toxoplasmosis; the modern diagnosis was by biopsy rather than removal of the mass.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1979 and 1983 operations",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I25.10",
            "display": "Atherosclerotic heart disease of native coronary artery without angina pectoris",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic modern diagnosis; the history remains D.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-004",
        "display": "Old myocardial infarction at age 36",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I25.2",
            "display": "Old myocardial infarction",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic coded history of the documented 1979 heart attack.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-005",
        "display": "Hyperlipidemia, on high-intensity statin",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E78.5",
            "display": "Hyperlipidemia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnosis; no cholesterol value from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesium",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1999667",
            "display": "bictegravir 50 MG / emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth once daily"
        },
        "start_date": "2025-09-25",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic antiretroviral therapy started in the hospital two weeks after toxoplasmosis treatment began; chosen for its high barrier to resistance and few interactions with his cardiac medicines.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intake",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198182",
            "display": "pyrimethamine 25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 3,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Three tablets by mouth daily after a 200 mg loading dose"
        },
        "start_date": "2025-09-11",
        "end_date": "2025-10-23",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic six-week acute treatment of cerebral toxoplasmosis.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intake",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198228",
            "display": "sulfadiazine 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 3,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "Three tablets by mouth every 6 hours"
        },
        "start_date": "2025-09-11",
        "end_date": "2025-10-23",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic six-week acute treatment of cerebral toxoplasmosis.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intake",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197860",
            "display": "leucovorin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Two tablets by mouth daily"
        },
        "start_date": "2025-09-11",
        "end_date": "2025-10-23",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic folinic acid to prevent pyrimethamine bone-marrow toxicity.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198335",
            "display": "sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet by mouth twice daily"
        },
        "start_date": "2025-10-23",
        "end_date": "2026-10-19",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic chronic maintenance therapy for toxoplasmosis that also prevents Pneumocystis pneumonia; stopped when the CD4 count had been above 200 for more than six months with an undetectable viral load.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "308416",
            "display": "aspirin 81 MG Delayed Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2016-07-31",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic lifelong low-dose aspirin after myocardial infarction and bypass surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Atorvastatin 80 mg oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "259255",
            "display": "atorvastatin 80 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2016-08-01",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic high-intensity statin since the myocardial infarction; no interaction with bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Ezetimibe 10 mg oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "349556",
            "display": "ezetimibe 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-01-12",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic add-on therapy for LDL cholesterol above 55 mg/dL on maximal statin.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198039",
            "display": "nitroglycerin 0.4 MG Sublingual Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "sublingual",
        "frequency": {
          "period": 5,
          "period_unit": "min",
          "text": "One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses"
        },
        "start_date": "2016-08-01",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic as-needed nitrate with a written chest-pain plan; not used during the episode.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "as_needed": true
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-VL-V1",
        "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
        "label": "HIV-1 viral load",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 42,
        "unit": "{copies}/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20447-9",
            "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic viral load after about 15 weeks of antiretroviral therapy; falling from 186,000 copies/mL at diagnosis but not yet below 20.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CD4-V1",
        "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
        "label": "CD4 count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 156,
        "unit": "/uL",
        "reference_range": {
          "low": 500,
          "high": 1500
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24467-3",
            "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic CD4 count recovering from 58 cells/uL at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 4.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole; mild anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 13.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole; mild anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 198,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole; mild anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on bictegravir and trimethoprim-sulfamethoxazole, both of which block tubular secretion of creatinine; creatinine 0.98 mg/dL before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 4.9,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on bictegravir and trimethoprim-sulfamethoxazole, both of which block tubular secretion of creatinine; creatinine 0.98 mg/dL before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 1.18,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on bictegravir and trimethoprim-sulfamethoxazole, both of which block tubular secretion of creatinine; creatinine 0.98 mg/dL before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 78,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on bictegravir and trimethoprim-sulfamethoxazole, both of which block tubular secretion of creatinine; creatinine 0.98 mg/dL before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on bictegravir and trimethoprim-sulfamethoxazole, both of which block tubular secretion of creatinine; creatinine 0.98 mg/dL before treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 30,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver test on antiretroviral therapy and high-intensity statin.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 158,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 80 mg; LDL above the secondary-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 40,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 80 mg; LDL above the secondary-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 150,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 80 mg; LDL above the secondary-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 88,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 80 mg; LDL above the secondary-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "HbA1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-01-12",
        "value": 5.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diabetes screen; no diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-01-12",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen after a new diagnosis: mild symptoms, item 9 scored 0. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-01-12",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen, low risk. Not a claim about his real drinking.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V2",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and creatinine check on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V2",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 4.8,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and creatinine check on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 1.16,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and creatinine check on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 79,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and creatinine check on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V2",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-09",
        "value": 90,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and creatinine check on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-VL-V3",
        "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
        "label": "HIV-1 viral load",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 0,
        "unit": "{copies}/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20447-9",
            "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic viral load: HIV-1 RNA not detected (below 20 copies/mL), recorded as 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CD4-V3",
        "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
        "label": "CD4 count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 218,
        "unit": "/uL",
        "reference_range": {
          "low": 500,
          "high": 1500
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24467-3",
            "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic CD4 count, above 200 for the first time.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 4.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 13.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 224,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V3",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V3",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 4.7,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 1.15,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 80,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver test after adding ezetimibe.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V3",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 118,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel 13 weeks after adding ezetimibe; LDL at goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V3",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 41,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel 13 weeks after adding ezetimibe; LDL at goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V3",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 125,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel 13 weeks after adding ezetimibe; LDL at goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V3",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 52,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel 13 weeks after adding ezetimibe; LDL at goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-LPA-V3",
        "display": "Lipoprotein a [Mass/volume] in Serum or Plasma",
        "label": "Lipoprotein(a)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 24,
        "unit": "mg/dL",
        "reference_range": {
          "high": 29
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10835-7",
            "display": "Lipoprotein a [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic one-time lipoprotein(a), not elevated.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-HBSAB-V3",
        "display": "Hepatitis B virus surface Ab [Units/volume] in Serum",
        "label": "Hepatitis B surface antibody",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 86,
        "unit": "m[IU]/mL",
        "reference_range": {
          "low": 10
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "16935-9",
            "display": "Hepatitis B virus surface Ab [Units/volume] in Serum",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antibody check nine weeks after the second hepatitis B vaccine dose; protective.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-VL-V4",
        "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
        "label": "HIV-1 viral load",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 0,
        "unit": "{copies}/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20447-9",
            "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic viral load: HIV-1 RNA not detected (below 20 copies/mL), recorded as 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CD4-V4",
        "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
        "label": "CD4 count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 262,
        "unit": "/uL",
        "reference_range": {
          "low": 500,
          "high": 1500
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24467-3",
            "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic CD4 count, still rising.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 1.14,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 80,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 93,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on trimethoprim-sulfamethoxazole and bictegravir.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V4",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-13",
        "value": 12,
        "unit": "mg/g",
        "reference_range": {
          "high": 29
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin check on tenofovir alafenamide, done late (see the protocol deviation recorded at the four-week visit).",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-13",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month depression screen; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-08-17",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V6",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-08-17",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly alcohol screen, low risk.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-VL-V5",
        "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
        "label": "HIV-1 viral load",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 0,
        "unit": "{copies}/mL",
        "reference_range": {
          "high": 20,
          "text": "Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "20447-9",
            "display": "HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic viral load: HIV-1 RNA not detected (below 20 copies/mL), recorded as 0.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CD4-V5",
        "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
        "label": "CD4 count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 318,
        "unit": "/uL",
        "reference_range": {
          "low": 500,
          "high": 1500
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "24467-3",
            "display": "CD3+CD4+ (T4 helper) cells [#/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic CD4 count, above 200 for more than six months.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 5.0,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole before it was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 14.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole before it was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 236,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count on trimethoprim-sulfamethoxazole before it was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before trimethoprim-sulfamethoxazole was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 4.5,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before trimethoprim-sulfamethoxazole was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 1.12,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before trimethoprim-sulfamethoxazole was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 82,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before trimethoprim-sulfamethoxazole was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-19",
        "value": 91,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel before trimethoprim-sulfamethoxazole was stopped.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Coronary artery bypass grafting, four grafts, after a myocardial infarction at age 36",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "232717009",
            "display": "Coronary artery bypass graft",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2016-12-13",
          "end": "2016-12-13"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern counterpart of the documented 1979 quadruple bypass; the day is synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Repeat coronary artery bypass grafting, two grafts, for recurrent angina; blood transfusion given",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "232717009",
            "display": "Coronary artery bypass graft",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2020-06-15",
          "end": "2020-06-15"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern counterpart of the documented 1983 double bypass; the day is synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "MRI of the head with contrast: single ring-enhancing lesion in the left frontoparietal region with surrounding edema",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "241601008",
            "display": "MRI of head",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2025-09-08",
          "end": "2025-09-08"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic imaging at the presentation with right-hand weakness.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Stereotactic biopsy of the left frontoparietal lesion: necrotizing inflammation with Toxoplasma gondii organisms; no lymphoma",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "171491002",
            "display": "Stereotactic biopsy of brain",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2025-09-10",
          "end": "2025-09-10"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic modern counterpart of the documented 1988 brain operation; done before the HIV result was available, because a single lesion raised concern for a tumor.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "12-lead electrocardiogram: sinus rhythm 72/min, old inferior Q waves, no acute ST change",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-01-12",
          "end": "2026-01-12"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic baseline ECG at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "period": {
          "start": "2026-08-17",
          "end": "2026-08-17"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the preventive visit; no specific treatment preference is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2021-05-03",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Influenza vaccine, 2025-2026 season, given in the hospital",
        "status": "completed",
        "date": "2025-09-18",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic inactivated influenza vaccination during the diagnostic admission.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-01-12",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose recommended for adults with HIV.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-01-12",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hepatitis B vaccination; hepatitis B surface antigen, surface antibody, and core antibody were all negative in the hospital.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Meningococcal conjugate vaccine MenACWY, dose 1 of 2",
        "status": "completed",
        "date": "2026-01-12",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "203",
            "display": "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic two-dose primary series recommended for adults with HIV.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 2 of 2",
        "status": "completed",
        "date": "2026-02-09",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose four weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Meningococcal conjugate vaccine MenACWY, dose 2 of 2",
        "status": "completed",
        "date": "2026-04-13",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "203",
            "display": "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose at least eight weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-008",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-04-13",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recombinant zoster vaccination, recommended from age 18 for adults with HIV.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-009",
        "display": "Recombinant zoster vaccine, dose 2 of 2",
        "status": "completed",
        "date": "2026-08-17",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose four months after the first, at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-010",
        "display": "Influenza vaccine, 2026-2027 season",
        "status": "completed",
        "date": "2026-10-19",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly inactivated influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "IMM-011",
        "display": "COVID-19 vaccine, 2026-2027 formula",
        "status": "completed",
        "date": "2026-10-19",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "MTH",
          "display": "mother"
        },
        "condition": "Died at 27 of complications from surgery; atherosclerotic heart disease at an early age reported",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "FH-002",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "FTH",
          "display": "father"
        },
        "condition": "Heart attacks at 55 and 59; atherosclerotic heart disease at an early age reported",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Heart attack at age 36 while teaching tennis to young people, followed by quadruple coronary artery bypass surgery",
        "historical_date": {
          "iso": "1979-07-31",
          "display": "July 31, 1979",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Second (double) bypass operation for recurrent chest pain, with a blood transfusion",
        "historical_date": {
          "iso": "1983",
          "display": "1983",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Right-arm weakness from a left-sided brain mass, removed and found to be toxoplasmosis; HIV and AIDS diagnosed, believed to have been acquired from the transfusion during the 1983 operation",
        "historical_date": {
          "iso": "1988",
          "display": "1988",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing primary care for HIV after a recent diagnosis with cerebral toxoplasmosis, and for coronary artery disease after two bypass operations",
        "status": "finished",
        "date": "2026-01-12",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Four-week check of potassium and creatinine, second hepatitis B vaccine, and infectious diseases consultation",
        "status": "finished",
        "date": "2026-02-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Four-week potassium and creatinine check, second hepatitis B vaccine, and same-day infectious diseases consultation",
          "hpi": {
            "narrative": "Mr. Ashe returns four weeks after his first visit and is seen by Dr. Rao of infectious diseases on the same day. He takes bictegravir, emtricitabine, and tenofovir alafenamide each morning and trimethoprim-sulfamethoxazole twice a day, and has missed no doses. He started ezetimibe four weeks ago without muscle aches. He has had no headache, seizure, or weakness, and his right hand feels normal. He has had no rash, fever, cough, or breathlessness, and no chest pain. He is sleeping better than at the first visit and has started to coach again two afternoons a week. He has told no one new about his diagnosis and asked again that his results go only to him.",
            "elements": [
              {
                "label": "Adherence",
                "value": "No missed doses of any medicine"
              },
              {
                "label": "New medicine",
                "value": "Ezetimibe for four weeks; no side effects"
              },
              {
                "label": "Neurological",
                "value": "No headache, seizure, or weakness"
              },
              {
                "label": "Heart",
                "value": "No chest pain; no nitroglycerin use"
              },
              {
                "label": "Privacy",
                "value": "Results to him only, by secure message"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or night sweats; weight up 0.6 kg"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash on trimethoprim-sulfamethoxazole"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, numbness, or weakness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood improving; sleeping better; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well and composed; weight 72.6 kg, blood pressure 116/72"
            },
            {
              "system": "Skin and mouth",
              "finding": "No rash; no thrush"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no edema"
            },
            {
              "system": "Neurological",
              "finding": "Grip strength and fine finger movements equal on both sides; no focal deficit"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "HIV infection",
              "assessment": "Excellent adherence. Potassium 4.8 mmol/L and creatinine 1.16 mg/dL, unchanged from four weeks ago. The creatinine rise since before treatment (0.98 mg/dL) is expected: bictegravir and trimethoprim both block tubular secretion of creatinine without lowering the true filtration rate. Dr. Rao agrees with continuing the current regimen",
              "plan": [
                "Continue bictegravir, emtricitabine, and tenofovir alafenamide",
                "Viral load, CD4 count, blood count, metabolic panel, ALT, and lipids at three months",
                "Urine albumin-to-creatinine ratio with the three-month blood tests"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Cerebral toxoplasmosis on maintenance therapy",
              "assessment": "No neurological symptoms; right hand normal",
              "plan": [
                "Continue trimethoprim-sulfamethoxazole until the CD4 count has been above 200 for more than six months with an undetectable viral load"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Coronary artery disease after two bypass operations",
              "assessment": "No angina; blood pressure at goal; ezetimibe tolerated",
              "plan": [
                "Lipid panel with the three-month blood tests"
              ]
            },
            {
              "display": "Vaccines",
              "assessment": "Second hepatitis B vaccine dose due today",
              "plan": [
                "Hepatitis B vaccine dose 2 given today",
                "Second meningococcal dose and first zoster dose at three months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HIV-1 viral load",
              "cadence": "4 to 8 weeks after starting ART, every 4 to 8 weeks until suppressed, then every 3 months",
              "status": "up_to_date",
              "detail": "42 copies/mL four weeks ago, falling from 186,000 at diagnosis; next at three months",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CD4 count",
              "cadence": "Every 3 months while below 200 and on prophylaxis; every 3 to 6 months in the first 2 years of ART",
              "status": "up_to_date",
              "detail": "156 cells/uL four weeks ago; next at three months",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HIV genotype resistance test",
              "cadence": "At diagnosis, before ART; again if the viral load rebounds",
              "status": "up_to_date",
              "detail": "No resistance mutations on the genotype sent before ART in the hospital",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HLA-B*5701 test",
              "cadence": "Only before abacavir is considered",
              "status": "not_indicated",
              "detail": "Abacavir is avoided because of its association with myocardial infarction in people with coronary disease",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "ART adherence and drug-interaction review (antacids, calcium, iron, new medicines)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No missed doses; no antacid, calcium, iron, or new medicine",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Complete blood count",
              "cadence": "Every 3 months on trimethoprim-sulfamethoxazole; every 3 to 6 months on ART",
              "status": "up_to_date",
              "detail": "Hemoglobin 13.0 g/dL, white cells 4.2, platelets 198 four weeks ago; next at three months",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine, and eGFR",
              "cadence": "1 to 4 weeks after starting trimethoprim-sulfamethoxazole, then every 3 to 6 months",
              "status": "completed_today",
              "detail": "Potassium 4.8 mmol/L, creatinine 1.16 mg/dL, eGFR 79; stable",
              "observation_ids": [
                "OBS-NA-V2",
                "OBS-K-V2",
                "OBS-CR-V2",
                "OBS-EGFR-V2",
                "OBS-GLU-V2"
              ],
              "guideline_ids": [
                "GL-DHHS-OI",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio on tenofovir",
              "cadence": "At the start of tenofovir and yearly",
              "status": "deferred",
              "detail": "Not done when tenofovir alafenamide was started in the hospital or at intake, a deviation from the DHHS and HIVMA guidance. Creatinine is stable, so no harm is evident. Corrective action: urine albumin-to-creatinine ratio ordered with the three-month blood tests",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT",
              "cadence": "Every 6 months on ART; with symptoms on a statin",
              "status": "up_to_date",
              "detail": "ALT 30 U/L four weeks ago",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Toxoplasma maintenance therapy and stopping criteria",
              "cadence": "Continue until CD4 above 200 for more than 6 months on ART with a suppressed viral load",
              "status": "completed_today",
              "detail": "Trimethoprim-sulfamethoxazole double strength twice daily, the alternative maintenance regimen; CD4 156, so it continues",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis prophylaxis",
              "cadence": "While CD4 below 200; stop after more than 3 months above 200",
              "status": "completed_today",
              "detail": "Covered by the trimethoprim-sulfamethoxazole maintenance dose",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Mycobacterium avium complex prophylaxis",
              "cadence": "Not recommended for people who start ART promptly",
              "status": "not_indicated",
              "detail": "On fully active ART since the hospital",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurological check: headache, seizure, weakness, and right-hand strength",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No symptoms; grip and fine finger movements equal",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Hepatitis B vaccine series and antibody check",
              "cadence": "Two doses four weeks apart; surface antibody 1 to 2 months after the last dose",
              "status": "completed_today",
              "detail": "Dose 2 given today; antibody check at three months",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Meningococcal ACWY vaccine",
              "cadence": "Two doses at least 8 weeks apart, then every 5 years",
              "status": "up_to_date",
              "detail": "Dose 1 four weeks ago; dose 2 at three months",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Live vaccines (MMR, varicella)",
              "cadence": "Contraindicated while CD4 below 200",
              "status": "not_indicated",
              "detail": "CD4 156; immune to measles, mumps, rubella, and varicella by serology in the hospital",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychosocial support, disclosure on his terms, and U=U counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Results go to him alone by secure message; he has not chosen to tell anyone new; peer support group details given again",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9 or PHQ-2)",
              "cadence": "At intake, at six months, and yearly",
              "status": "up_to_date",
              "detail": "PHQ-9 5 four weeks ago; mood improving",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure (goal below 130/80)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "116/72 mmHg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, BMI, and physical activity",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "72.6 kg, BMI 21.2; coaching two afternoons a week",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Coronary medicine adherence: aspirin 81 mg, high-intensity statin, ezetimibe",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Taking all three; atorvastatin 80 mg has no interaction with bictegravir",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Beta-blocker",
              "cadence": "First year after myocardial infarction, or with LVEF 50 percent or less, angina, or another indication",
              "status": "not_indicated",
              "detail": "Myocardial infarction ten years ago; no angina, heart failure, or arrhythmia; blood pressure normal",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Angina review and chest-pain plan",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No angina; nitroglycerin not used; chest-pain plan reviewed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after a change, then every 3 to 12 months; yearly when stable",
              "status": "due",
              "detail": "LDL 88 mg/dL at intake; ezetimibe added; recheck with the three-month blood tests",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipoprotein(a), once in adulthood",
              "cadence": "Once in adulthood",
              "status": "due",
              "detail": "Not on record; with the three-month blood tests",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Stress testing, coronary imaging, or echocardiography",
              "cadence": "Only with new or worsening symptoms; routine surveillance not recommended",
              "status": "not_indicated",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "referral",
              "measure": "Infectious diseases consultation",
              "cadence": "At diagnosis, then as advised",
              "status": "completed_today",
              "detail": "Seen by Dr. Rao today",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024",
                "GL-DHHS-OI"
              ]
            }
          ],
          "follow_up": "Three-month visit with blood and urine tests, the second meningococcal dose, and the first zoster dose. Results by secure message",
          "guideline_ids": [
            "GL-DHHS-ART",
            "GL-IAS-ART-2024",
            "GL-DHHS-OI",
            "GL-HIVMA-PC-2020",
            "GL-CDC-IMZ-HIV",
            "GL-CCD-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Three-month HIV and lipid review",
        "status": "finished",
        "date": "2026-04-13",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Three-month HIV and lipid review",
          "hpi": {
            "narrative": "Mr. Ashe returns three months after his first visit, about seven months after starting antiretroviral therapy. He has missed no doses. He has had no headache, weakness, rash, fever, or chest pain. He is coaching four afternoons a week and hitting balls three times a week without angina. He has had no muscle aches on atorvastatin and ezetimibe. His blood tests were drawn this morning. He left before giving a urine sample, so the urine albumin test ordered at the last visit was not done. He feels more like himself and says that worry about his privacy comes and goes.",
            "elements": [
              {
                "label": "Adherence",
                "value": "No missed doses"
              },
              {
                "label": "Activity",
                "value": "Coaching four afternoons a week; tennis drills without angina"
              },
              {
                "label": "Side effects",
                "value": "None"
              },
              {
                "label": "Urine test",
                "value": "Not collected this morning"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or night sweats; weight up 1.2 kg"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, or weakness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 73.8 kg, blood pressure 120/74"
            },
            {
              "system": "Mouth",
              "finding": "No thrush"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no edema"
            },
            {
              "system": "Neurological",
              "finding": "Grip and fine finger movements equal on both sides"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "HIV infection",
              "assessment": "Viral load not detected (below 20 copies/mL): the goal of therapy is reached. CD4 count 218, above 200 for the first time. Blood count normal: hemoglobin 13.6 g/dL, white cells 4.6, platelets 224. Potassium 4.7 mmol/L and creatinine 1.15 mg/dL, stable. Hepatitis B surface antibody 86 mIU/mL: protected. He was told that once the viral load has stayed undetectable for six months, HIV is not transmitted sexually",
              "plan": [
                "Continue the same regimen",
                "Viral load, CD4 count, metabolic panel, and urine albumin at six months"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Cerebral toxoplasmosis on maintenance therapy",
              "assessment": "No symptoms. CD4 now above 200; maintenance can stop once it has stayed above 200 for more than six months",
              "plan": [
                "Continue trimethoprim-sulfamethoxazole; reassess at the nine-month visit"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Hyperlipidemia",
              "assessment": "LDL 52 mg/dL on atorvastatin and ezetimibe, below the goal of 55, from 88 at intake. Triglycerides 125, HDL 41. ALT 27 U/L. Lipoprotein(a) 24 mg/dL, not elevated. The recheck came 13 weeks after ezetimibe was added, one week outside the 4 to 12 week window, with no effect on care",
              "plan": [
                "Continue atorvastatin 80 mg and ezetimibe 10 mg",
                "Yearly lipid panel"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Coronary artery disease after two bypass operations",
              "assessment": "No angina with regular vigorous exercise; blood pressure at goal",
              "plan": [
                "Continue aspirin and the chest-pain plan"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HIV-1 viral load",
              "cadence": "4 to 8 weeks after starting ART, every 4 to 8 weeks until suppressed, then every 3 months",
              "status": "completed_today",
              "detail": "Not detected (below 20 copies/mL), from 42 three months ago",
              "observation_ids": [
                "OBS-VL-V3"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CD4 count",
              "cadence": "Every 3 months while below 200 and on prophylaxis; every 3 to 6 months in the first 2 years of ART",
              "status": "completed_today",
              "detail": "218 cells/uL, above 200 for the first time",
              "observation_ids": [
                "OBS-CD4-V3"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "ART adherence and drug-interaction review (antacids, calcium, iron, new medicines)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No missed doses; no interacting medicines",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Complete blood count",
              "cadence": "Every 3 months on trimethoprim-sulfamethoxazole; every 3 to 6 months on ART",
              "status": "completed_today",
              "detail": "Hemoglobin 13.6 g/dL, white cells 4.6, platelets 224",
              "observation_ids": [
                "OBS-WBC-V3",
                "OBS-HGB-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine, and eGFR",
              "cadence": "1 to 4 weeks after starting trimethoprim-sulfamethoxazole, then every 3 to 6 months",
              "status": "completed_today",
              "detail": "Potassium 4.7 mmol/L, creatinine 1.15 mg/dL, eGFR 80",
              "observation_ids": [
                "OBS-NA-V3",
                "OBS-K-V3",
                "OBS-CR-V3",
                "OBS-EGFR-V3",
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-DHHS-OI",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio on tenofovir",
              "cadence": "At the start of tenofovir and yearly",
              "status": "deferred",
              "detail": "Ordered after the deviation recorded at the four-week visit, but the sample was not collected this morning: a second miss. Creatinine is stable, so no harm is evident. Corrective action: the urine sample is now part of the standing order for each blood draw, starting at six months",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT",
              "cadence": "Every 6 months on ART; with symptoms on a statin",
              "status": "completed_today",
              "detail": "ALT 27 U/L",
              "observation_ids": [
                "OBS-ALT-V3"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Toxoplasma maintenance therapy and stopping criteria",
              "cadence": "Continue until CD4 above 200 for more than 6 months on ART with a suppressed viral load",
              "status": "completed_today",
              "detail": "CD4 above 200 for the first time; continue for at least six more months",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis prophylaxis",
              "cadence": "While CD4 below 200; stop after more than 3 months above 200",
              "status": "completed_today",
              "detail": "Covered by the maintenance dose",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurological check: headache, seizure, weakness, and right-hand strength",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No symptoms; strength equal",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B vaccine series and antibody check",
              "cadence": "Two doses four weeks apart; surface antibody 1 to 2 months after the last dose",
              "status": "completed_today",
              "detail": "Surface antibody 86 mIU/mL nine weeks after dose 2: protected",
              "observation_ids": [
                "OBS-HBSAB-V3"
              ],
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Meningococcal ACWY vaccine",
              "cadence": "Two doses at least 8 weeks apart, then every 5 years",
              "status": "completed_today",
              "detail": "Dose 2 given today, thirteen weeks after dose 1; booster in five years",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Recombinant zoster vaccine",
              "cadence": "Two doses 2 to 6 months apart, from age 18 with HIV",
              "status": "completed_today",
              "detail": "Dose 1 given today",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychosocial support, disclosure on his terms, and U=U counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Worry about privacy comes and goes; U=U explained; peer support offered again",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9 or PHQ-2)",
              "cadence": "At intake, at six months, and yearly",
              "status": "up_to_date",
              "detail": "PHQ-9 5 at intake; mood good; next at six months",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure (goal below 130/80)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "120/74 mmHg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, BMI, and physical activity",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "73.8 kg, BMI 21.6; regaining weight lost during his illness",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Coronary medicine adherence: aspirin 81 mg, high-intensity statin, ezetimibe",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Taking all three; no muscle aches",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Angina review and chest-pain plan",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No angina with tennis drills; nitroglycerin not used",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after a change, then every 3 to 12 months; yearly when stable",
              "status": "completed_today",
              "detail": "LDL 52 mg/dL, at goal; drawn 13 weeks after the change, one week outside the window, with no effect on care",
              "observation_ids": [
                "OBS-CHOL-V3",
                "OBS-HDL-V3",
                "OBS-TG-V3",
                "OBS-LDL-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipoprotein(a), once in adulthood",
              "cadence": "Once in adulthood",
              "status": "completed_today",
              "detail": "24 mg/dL, not elevated; no repeat needed",
              "observation_ids": [
                "OBS-LPA-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Stress testing, coronary imaging, or echocardiography",
              "cadence": "Only with new or worsening symptoms; routine surveillance not recommended",
              "status": "not_indicated",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            }
          ],
          "follow_up": "Six-month visit with viral load, CD4 count, metabolic panel, urine albumin, and the PHQ-9. Results by secure message",
          "guideline_ids": [
            "GL-DHHS-ART",
            "GL-IAS-ART-2024",
            "GL-DHHS-OI",
            "GL-HIVMA-PC-2020",
            "GL-CDC-IMZ-HIV",
            "GL-CCD-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Six-month HIV and coronary disease review with depression screening",
        "status": "finished",
        "date": "2026-07-13",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Six-month HIV and coronary disease review with depression screening",
          "hpi": {
            "narrative": "Mr. Ashe returns six months after his first visit. He has missed no doses. He has had no headache, weakness, rash, fever, or chest pain, and has not needed nitroglycerin. He is back to full-time writing and coaching. He gave a urine sample with this morning's blood tests. He answered the PHQ-9 with a score of 2 and has no thoughts of self-harm. He says that knowing his viral load is undetectable has eased his mind.",
            "elements": [
              {
                "label": "Adherence",
                "value": "No missed doses"
              },
              {
                "label": "Work",
                "value": "Full-time writing and coaching"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 2; item 9 scored 0"
              },
              {
                "label": "Heart",
                "value": "No angina; nitroglycerin not used"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; weight up 0.8 kg"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, or weakness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-9 score 2; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 74.6 kg, blood pressure 118/72"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no edema"
            },
            {
              "system": "Neurological",
              "finding": "No focal deficit"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "HIV infection",
              "assessment": "Viral load not detected for the second time; CD4 count 262. Potassium 4.6 mmol/L, creatinine 1.14 mg/dL. Urine albumin-to-creatinine ratio 12 mg/g, normal, closing the deviation recorded at the earlier visits",
              "plan": [
                "Continue the same regimen",
                "Viral load, CD4 count, blood count, and metabolic panel at nine months",
                "Urine albumin yearly"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Cerebral toxoplasmosis on maintenance therapy",
              "assessment": "No symptoms; CD4 above 200 for three months",
              "plan": [
                "Continue trimethoprim-sulfamethoxazole; if the CD4 count is still above 200 at nine months, stop it"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Coronary artery disease after two bypass operations",
              "assessment": "No angina; blood pressure at goal; LDL 52 mg/dL three months ago. PHQ-9 2",
              "plan": [
                "Continue aspirin, atorvastatin, and ezetimibe"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HIV-1 viral load",
              "cadence": "4 to 8 weeks after starting ART, every 4 to 8 weeks until suppressed, then every 3 months",
              "status": "completed_today",
              "detail": "Not detected (below 20 copies/mL), the second undetectable result",
              "observation_ids": [
                "OBS-VL-V4"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CD4 count",
              "cadence": "Every 3 months while below 200 and on prophylaxis; every 3 to 6 months in the first 2 years of ART",
              "status": "completed_today",
              "detail": "262 cells/uL",
              "observation_ids": [
                "OBS-CD4-V4"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "ART adherence and drug-interaction review (antacids, calcium, iron, new medicines)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No missed doses; no interacting medicines",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Complete blood count",
              "cadence": "Every 3 months on trimethoprim-sulfamethoxazole; every 3 to 6 months on ART",
              "status": "up_to_date",
              "detail": "Normal three months ago; next at nine months",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine, and eGFR",
              "cadence": "1 to 4 weeks after starting trimethoprim-sulfamethoxazole, then every 3 to 6 months",
              "status": "completed_today",
              "detail": "Potassium 4.6 mmol/L, creatinine 1.14 mg/dL, eGFR 80",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4",
                "OBS-GLU-V4"
              ],
              "guideline_ids": [
                "GL-DHHS-OI",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio on tenofovir",
              "cadence": "At the start of tenofovir and yearly",
              "status": "completed_today",
              "detail": "Albumin-to-creatinine ratio 12 mg/g, normal; collected late after the deviations recorded at four weeks and three months; no harm resulted",
              "observation_ids": [
                "OBS-UACR-V4"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT",
              "cadence": "Every 6 months on ART; with symptoms on a statin",
              "status": "up_to_date",
              "detail": "ALT 27 U/L three months ago",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Toxoplasma maintenance therapy and stopping criteria",
              "cadence": "Continue until CD4 above 200 for more than 6 months on ART with a suppressed viral load",
              "status": "completed_today",
              "detail": "CD4 above 200 for three months; continue to nine months",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis prophylaxis",
              "cadence": "While CD4 below 200; stop after more than 3 months above 200",
              "status": "completed_today",
              "detail": "CD4 above 200 for three months; covered by the maintenance dose, which continues",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurological check: headache, seizure, weakness, and right-hand strength",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Recombinant zoster vaccine",
              "cadence": "Two doses 2 to 6 months apart, from age 18 with HIV",
              "status": "due",
              "detail": "Dose 2 at the preventive visit next month",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychosocial support, disclosure on his terms, and U=U counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Reassured by his undetectable results; disclosure remains his decision",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9 or PHQ-2)",
              "cadence": "At intake, at six months, and yearly",
              "status": "completed_today",
              "detail": "PHQ-9 2, with item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure (goal below 130/80)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "118/72 mmHg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, BMI, and physical activity",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "74.6 kg, BMI 21.8; full-time work and exercise three times a week",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Coronary medicine adherence: aspirin 81 mg, high-intensity statin, ezetimibe",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Taking all three",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Angina review and chest-pain plan",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No angina",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after a change, then every 3 to 12 months; yearly when stable",
              "status": "up_to_date",
              "detail": "LDL 52 mg/dL three months ago; yearly from now on",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Stress testing, coronary imaging, or echocardiography",
              "cadence": "Only with new or worsening symptoms; routine surveillance not recommended",
              "status": "not_indicated",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            }
          ],
          "follow_up": "Preventive visit next month with the second zoster dose. Nine-month HIV review with blood tests",
          "guideline_ids": [
            "GL-DHHS-ART",
            "GL-IAS-ART-2024",
            "GL-DHHS-OI",
            "GL-HIVMA-PC-2020",
            "GL-CDC-IMZ-HIV",
            "GL-CCD-2023",
            "GL-CMID-2026",
            "GL-USPSTF-DEP-2023"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Nine-month HIV review: decision to stop toxoplasmosis maintenance therapy",
        "status": "finished",
        "date": "2026-10-19",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Nine-month HIV review: decision about stopping toxoplasmosis maintenance therapy",
          "hpi": {
            "narrative": "Mr. Ashe returns nine months after his first visit, about thirteen months after starting antiretroviral therapy. He has missed no doses and has had no headache, weakness, seizure, rash, fever, or chest pain. His colonoscopy appointment is next month. He has read the result of the syphilis test from the preventive visit, which was sent to him by secure message. He has thought about anal cancer screening and would like to have it at his next visit. Today's blood tests were drawn this morning.",
            "elements": [
              {
                "label": "Adherence",
                "value": "No missed doses"
              },
              {
                "label": "Symptoms",
                "value": "None"
              },
              {
                "label": "Screening",
                "value": "Colonoscopy booked; anal cancer screening chosen for the next visit"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; weight stable"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, or weakness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 75.0 kg, blood pressure 120/74"
            },
            {
              "system": "Mouth",
              "finding": "No thrush"
            },
            {
              "system": "Neurological",
              "finding": "No focal deficit; strength equal on both sides"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Cerebral toxoplasmosis on maintenance therapy",
              "assessment": "All criteria for stopping maintenance are met: six weeks of acute treatment completed, no symptoms, viral load undetectable since three months, and CD4 above 200 for more than six months (218, 262, and now 318). The same counts allow Pneumocystis prophylaxis to stop",
              "plan": [
                "Stop trimethoprim-sulfamethoxazole today",
                "Restart it if the CD4 count falls below 200",
                "Report any headache, weakness, seizure, or fever the same day"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "HIV infection",
              "assessment": "Viral load not detected for the third time; CD4 318. Blood count normal: hemoglobin 14.1 g/dL, white cells 5.0, platelets 236. Potassium 4.5 mmol/L and creatinine 1.12 mg/dL",
              "plan": [
                "Continue the same regimen",
                "Viral load and CD4 count in three months, then every three to six months",
                "Influenza and COVID-19 vaccines today"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Coronary artery disease after two bypass operations",
              "assessment": "No angina; blood pressure at goal",
              "plan": [
                "Yearly lipid panel at the next visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HIV-1 viral load",
              "cadence": "4 to 8 weeks after starting ART, every 4 to 8 weeks until suppressed, then every 3 months",
              "status": "completed_today",
              "detail": "Not detected (below 20 copies/mL), the third undetectable result",
              "observation_ids": [
                "OBS-VL-V5"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "CD4 count",
              "cadence": "Every 3 months while below 200 and on prophylaxis; every 3 to 6 months in the first 2 years of ART",
              "status": "completed_today",
              "detail": "318 cells/uL, above 200 for more than six months",
              "observation_ids": [
                "OBS-CD4-V5"
              ],
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "ART adherence and drug-interaction review (antacids, calcium, iron, new medicines)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No missed doses; no interacting medicines",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Complete blood count",
              "cadence": "Every 3 months on trimethoprim-sulfamethoxazole; every 3 to 6 months on ART",
              "status": "completed_today",
              "detail": "Hemoglobin 14.1 g/dL, white cells 5.0, platelets 236",
              "observation_ids": [
                "OBS-WBC-V5",
                "OBS-HGB-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine, and eGFR",
              "cadence": "1 to 4 weeks after starting trimethoprim-sulfamethoxazole, then every 3 to 6 months",
              "status": "completed_today",
              "detail": "Potassium 4.5 mmol/L, creatinine 1.12 mg/dL, eGFR 82",
              "observation_ids": [
                "OBS-NA-V5",
                "OBS-K-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5",
                "OBS-GLU-V5"
              ],
              "guideline_ids": [
                "GL-DHHS-OI",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio on tenofovir",
              "cadence": "At the start of tenofovir and yearly",
              "status": "up_to_date",
              "detail": "Normal three months ago; next in one year",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT",
              "cadence": "Every 6 months on ART; with symptoms on a statin",
              "status": "due",
              "detail": "ALT 27 U/L six months ago; with the lipid panel at the next visit",
              "guideline_ids": [
                "GL-DHHS-ART",
                "GL-IAS-ART-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Toxoplasma maintenance therapy and stopping criteria",
              "cadence": "Continue until CD4 above 200 for more than 6 months on ART with a suppressed viral load",
              "status": "completed_today",
              "detail": "Criteria met; trimethoprim-sulfamethoxazole stopped today; restart if CD4 falls below 200",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis prophylaxis",
              "cadence": "While CD4 below 200; stop after more than 3 months above 200",
              "status": "completed_today",
              "detail": "CD4 above 200 for more than three months; prophylaxis stops with the maintenance dose",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurological check: headache, seizure, weakness, and right-hand strength",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No symptoms; same-day review if any develop",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Syphilis screen",
              "cadence": "Yearly",
              "status": "up_to_date",
              "detail": "Drawn at the preventive visit; result reviewed with him; next in one year",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Influenza and COVID-19 vaccines",
              "cadence": "Each autumn",
              "status": "completed_today",
              "detail": "Inactivated influenza vaccine and COVID-19 vaccine given today",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV",
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Psychosocial support, disclosure on his terms, and U=U counseling",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Well supported; disclosure remains his decision",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9 or PHQ-2)",
              "cadence": "At intake, at six months, and yearly",
              "status": "up_to_date",
              "detail": "PHQ-2 0 two months ago",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure (goal below 130/80)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "120/74 mmHg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, BMI, and physical activity",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "75.0 kg, BMI 21.9; stable",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Coronary medicine adherence: aspirin 81 mg, high-intensity statin, ezetimibe",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Taking all three",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Angina review and chest-pain plan",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No angina",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after a change, then every 3 to 12 months; yearly when stable",
              "status": "due",
              "detail": "Yearly panel at the next visit",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Stress testing, coronary imaging, or echocardiography",
              "cadence": "Only with new or worsening symptoms; routine surveillance not recommended",
              "status": "not_indicated",
              "detail": "No symptoms",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-CCD-2023"
              ]
            }
          ],
          "follow_up": "HIV review in three months with viral load, CD4 count, lipid panel, ALT, and anal cancer screening. Colonoscopy next month. Same-day visit for headache, weakness, seizure, or fever",
          "guideline_ids": [
            "GL-DHHS-ART",
            "GL-IAS-ART-2024",
            "GL-DHHS-OI",
            "GL-HIVMA-PC-2020",
            "GL-CDC-IMZ-HIV",
            "GL-CCD-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-08-17",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit; no new concerns",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on a tablet in a private room before the visit and reviewed with him by Dr. Tolliver; kept in the confidential part of the record",
          "hpi": {
            "narrative": "Mr. Ashe is a 46-year-old man with HIV, diagnosed eleven months ago with cerebral toxoplasmosis and now well controlled on bictegravir, emtricitabine, and tenofovir alafenamide, and with coronary artery disease after two bypass operations, who comes for his yearly preventive visit five weeks after his six-month review. His viral load was not detected at three and six months, and his CD4 count was 262 last month. He takes every dose and knows to keep any antacid, calcium, or iron well apart from his HIV tablet; he has needed none. He has had no chest pain and has not needed nitroglycerin. He hits tennis balls three times a week and is back to full-time writing and coaching. His right hand has stayed strong. His weight has come back to where it was before his illness. Mood is good. He has told one more close friend about his diagnosis, on his own terms, and says that went well. He has no new concerns.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 46"
              },
              {
                "label": "HIV",
                "value": "Viral load not detected at three and six months; CD4 262 last month"
              },
              {
                "label": "Heart",
                "value": "No angina; no nitroglycerin use; exercising three times a week"
              },
              {
                "label": "Medicines",
                "value": "Bictegravir, emtricitabine, and tenofovir alafenamide; trimethoprim-sulfamethoxazole; aspirin; atorvastatin; ezetimibe; nitroglycerin as needed, not used"
              },
              {
                "label": "Safety events",
                "value": "No emergency visits or hospital stays since discharge"
              },
              {
                "label": "Disclosure",
                "value": "His own choice; has told one more close friend"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and better than at any time since his diagnosis"
            },
            {
              "domain": "Psychosocial",
              "finding": "Supported by his family and a few close friends; some worry about who might learn of his diagnosis; no loneliness"
            },
            {
              "domain": "Tobacco",
              "finding": "Never used tobacco or e-cigarettes"
            },
            {
              "domain": "Alcohol and drugs",
              "finding": "AUDIT-C 1; no other drug use"
            },
            {
              "domain": "Physical activity",
              "finding": "Tennis drills three times a week and daily walking; about 200 minutes a week"
            },
            {
              "domain": "Nutrition",
              "finding": "Mediterranean-style diet; regular meals"
            },
            {
              "domain": "Sleep",
              "finding": "Seven hours a night"
            },
            {
              "domain": "Sexual health",
              "finding": "One long-term partner; understands that an undetectable viral load means HIV is not transmitted sexually"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Home and road safety",
              "finding": "Wears a seat belt; smoke detectors working; no firearms in the home"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No concerns"
            },
            {
              "domain": "Oral health",
              "finding": "No dental visit in the past year"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight back to its usual level; no fever, night sweats, or fatigue"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No floaters, blurred vision, or eye pain"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth sores, white patches, or swallowing trouble"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal pain, diarrhea, or blood in the stool"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms, genital sores, or discharge"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches on atorvastatin and ezetimibe; no joint pain"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash or new skin lesions"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, numbness, or weakness; right hand strong"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0; no thoughts of self-harm"
            },
            {
              "system": "Hematologic and lymphatic",
              "status": "negative",
              "finding": "No easy bruising or swollen glands"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well and relaxed; weight 74.8 kg, BMI 21.9"
            },
            {
              "system": "Eyes",
              "finding": "Conjunctivae clear; pupils equal and reactive"
            },
            {
              "system": "Mouth",
              "finding": "No thrush, ulcers, or oral hairy leukoplakia; teeth and gums in fair repair"
            },
            {
              "system": "Neck and lymph nodes",
              "finding": "No enlarged nodes in the neck, armpits, or groins"
            },
            {
              "system": "Chest wall",
              "finding": "Healed sternotomy scar"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm at 64 per minute; no murmur; no edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; no liver or spleen enlargement"
            },
            {
              "system": "Skin",
              "finding": "No rash or suspicious lesions"
            },
            {
              "system": "Neurological",
              "finding": "Grip strength and fine finger movements equal on both sides; no focal deficit"
            },
            {
              "system": "Psychiatric",
              "finding": "Euthymic; good insight"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the personalized prevention plan updated. Depression and alcohol screens negative. Colorectal cancer screening is due from age 45, and anal cancer screening is now recommended for him as a person with HIV aged 45 or older",
              "plan": [
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "HIV infection",
              "assessment": "Viral load not detected and CD4 count rising; adherence excellent",
              "plan": [
                "Nine-month review in two months with viral load, CD4 count, blood count, and metabolic panel",
                "Syphilis test today, as recommended yearly for people with HIV"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Coronary artery disease after two bypass operations",
              "assessment": "No angina; blood pressure 118/72; LDL 52 mg/dL four months ago",
              "plan": [
                "Continue aspirin, atorvastatin, and ezetimibe"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "118/72 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Cholesterol and statin therapy",
              "status": "up_to_date",
              "detail": "Secondary prevention: LDL 52 mg/dL on atorvastatin 80 mg and ezetimibe; lipoprotein(a) 24 mg/dL; yearly lipid panel next due in the winter",
              "guideline_ids": [
                "GL-CCD-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "up_to_date",
              "detail": "HbA1c 5.4 percent at intake; recheck yearly on antiretroviral therapy",
              "guideline_ids": [
                "GL-USPSTF-AB",
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "service": "Healthy weight and activity",
              "status": "completed_today",
              "detail": "BMI 21.9; weight back to its level before his illness. Integrase inhibitors can cause weight gain, so weight is tracked at every visit",
              "guideline_ids": [
                "GL-IAS-ART-2024"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "Recommended from age 45; no prior screening. He chose colonoscopy, and a referral to gastroenterology was placed",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Anal cancer screening",
              "status": "due",
              "detail": "Recommended for people with HIV from age 45; the options (anal cytology with or without HPV testing, then high-resolution anoscopy if abnormal) were explained, and he will decide at the nine-month visit",
              "guideline_ids": [
                "GL-DHHS-OI"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "not_indicated",
              "detail": "Shared decision-making about PSA testing begins at age 55",
              "guideline_ids": [
                "GL-USPSTF-PROSTATE-2018"
              ]
            },
            {
              "service": "Lung cancer and abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "Never used tobacco",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0; PHQ-9 2 at the six-month review",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 1",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Syphilis screening",
              "status": "ordered",
              "detail": "Yearly for sexually active people with HIV; drawn today",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "service": "Gonorrhea and chlamydia screening",
              "status": "not_indicated",
              "detail": "One long-term partner and no symptoms; review yearly",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "up_to_date",
              "detail": "Antibody negative at diagnosis; repeat only if a risk arises",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "service": "Tuberculosis screening",
              "status": "up_to_date",
              "detail": "Interferon-gamma release assay negative at diagnosis",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "completed_today",
              "detail": "Dose 2 given today, four months after dose 1; series complete",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "up_to_date",
              "detail": "Two-dose series complete; surface antibody 86 mIU/mL four months ago",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "Meningococcal ACWY vaccine",
              "status": "up_to_date",
              "detail": "Two-dose series complete; booster every five years",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 given at intake",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "Hepatitis A vaccine",
              "status": "not_indicated",
              "detail": "Hepatitis A antibody positive at diagnosis; immune",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis booster",
              "status": "up_to_date",
              "detail": "Tdap five years ago; next booster in five years",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "Influenza and COVID-19 vaccines, this season",
              "status": "due",
              "detail": "Both at the nine-month visit in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "HPV vaccine",
              "status": "not_indicated",
              "detail": "Not recommended after age 45",
              "guideline_ids": [
                "GL-CDC-IMZ-HIV"
              ]
            },
            {
              "service": "Dental examination",
              "status": "due",
              "detail": "No dental visit in the past year; advised to book one, as recommended yearly for people with HIV",
              "guideline_ids": [
                "GL-HIVMA-PC-2020"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the confidential part of the chart and is not named here. He said that what matters most to him is staying active, his family, his work with young people, and keeping control of his own medical information. He chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness.",
          "follow_up": "Nine-month HIV review in two months, with the influenza and COVID-19 vaccines and his decision about anal cancer screening. Colonoscopy through gastroenterology. Syphilis result by secure message. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-HIVMA-PC-2020",
            "GL-CDC-IMZ-HIV",
            "GL-CMID-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit; no synthetic illness episode is added under the recent-death rule.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-01-12",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 72.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no blood pressure or weight from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-02-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 72.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 116,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no blood pressure or weight from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 73.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no blood pressure or weight from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-07-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 74.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 66,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no blood pressure or weight from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-19",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 75.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 66,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no blood pressure or weight from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-08-17",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 74.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit, continuing the trend of the earlier visits.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Former professional tennis player; now writes, broadcasts, and coaches young players; travels for work",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern occupation echoing his documented career and youth coaching.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Supports: married, with a young child, and close friends; has told only a few people about his HIV diagnosis",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic family and support history; no relative's health or decisions are recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Tobacco: never; alcohol: AUDIT-C 1, a glass of wine once or twice a week; no other substance use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern substance-use history; not a claim about his real habits.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Exercise: hits tennis balls for an hour three times a week and walks daily, without chest pain",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity history.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Sexual health: one partner; condoms used until his viral load is undetectable for six months; told that a person with HIV whose viral load stays undetectable does not transmit HIV sexually",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic person-first sexual-health counseling; no partner's health is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Right-hand weakness at diagnosis has recovered: grip and fine finger movements equal on both sides; writes and plays without difficulty",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic functional recovery after toxoplasmosis treatment.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "FUNC-002",
        "display": "Independent in all activities; vigorous exercise without angina or breathlessness",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, composed, and thoughtful; asks precise questions about his treatment",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood mostly good, with worry about his family and his privacy; PHQ-9 score 5 with item 9 scored 0; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "HIV infection diagnosed four months ago with cerebral toxoplasmosis and a CD4 count of 58, in a 45-year-old man who also has coronary artery disease after two bypass operations. Please review his antiretroviral regimen and its interactions with his cardiac medicines, and advise on opportunistic-infection prophylaxis, the monitoring schedule, and vaccines, so that we can co-manage his care",
        "urgency": "Routine, within four weeks, on the same day as his four-week primary care visit",
        "pertinent_history": "Admitted four months ago with right-hand weakness; MRI showed a single ring-enhancing left frontoparietal lesion, and stereotactic biopsy showed Toxoplasma. HIV was diagnosed during that admission, with a viral load of 186,000 copies/mL and a CD4 count of 58. The genotype showed no resistance mutations; hepatitis B surface antigen, surface antibody, and core antibody were negative; hepatitis C antibody negative; hepatitis A antibody positive; interferon-gamma release assay negative; Toxoplasma IgG positive. He completed six weeks of pyrimethamine, sulfadiazine, and leucovorin, and has taken trimethoprim-sulfamethoxazole double strength twice daily since. Bictegravir, emtricitabine, and tenofovir alafenamide were started two weeks into toxoplasmosis treatment. His right hand has recovered. Today, after about 15 weeks of therapy: viral load 42 copies/mL, CD4 156, hemoglobin 13.0 g/dL, potassium 4.9 mmol/L, creatinine 1.18 mg/dL (0.98 before treatment), ALT 30, LDL 88 mg/dL. Coronary disease: myocardial infarction at 36, quadruple bypass the same year, and a double bypass for recurrent angina at 39, with a blood transfusion during that operation; no angina now. He takes aspirin 81 mg and atorvastatin 80 mg, ezetimibe was added today, and he has sublingual nitroglycerin. PCV20, a first hepatitis B vaccine dose, and a first meningococcal ACWY dose were given today. He has asked that his diagnosis and results be shared with no one without his consent",
        "questions": [
          "Is bictegravir, emtricitabine, and tenofovir alafenamide the right long-term regimen for him, given his coronary disease and his cardiac medicines, and which antiretroviral drugs should he avoid?",
          "How long should trimethoprim-sulfamethoxazole maintenance continue, and does he need any other prophylaxis?",
          "What monitoring schedule do you advise for viral load, CD4 count, and drug safety, and how should we read the rise in his creatinine?",
          "Which vaccines does he need now, and which should wait for immune recovery?",
          "Does his HIV infection change the plan for his coronary risk factors?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Ashe, a 45-year-old man, is seen at the request of Dr. Tolliver for co-management of HIV. HIV was diagnosed four months ago when he presented with right-hand weakness from cerebral toxoplasmosis, confirmed by stereotactic biopsy; the CD4 count was 58 and the viral load 186,000 copies/mL. He completed six weeks of pyrimethamine, sulfadiazine, and leucovorin and has taken trimethoprim-sulfamethoxazole double strength twice daily since. He started bictegravir, emtricitabine, and tenofovir alafenamide two weeks into toxoplasmosis treatment and has missed no doses. He has had no headache, seizure, fever, rash, or cough, and his right hand has recovered. He acquired HIV, he understands, from a blood transfusion during his second bypass operation; the hospital reported the suspected transfusion-transmitted infection to the blood supplier at diagnosis. He has coronary artery disease after two bypass operations and has no angina. He is clear that he alone decides who learns of his diagnosis",
        "data_reviewed": "Hospital records, including the MRI, the biopsy report, the baseline genotype, and the hepatitis, tuberculosis, and Toxoplasma serologies. Dr. Tolliver's intake note four weeks ago, with the viral load (42 copies/mL), CD4 count (156), blood count, metabolic panel, ALT, lipid panel, and ECG. Today's metabolic panel, below",
        "exam": [
          {
            "system": "General",
            "finding": "Well and composed; weight 72.6 kg; blood pressure 116/72"
          },
          {
            "system": "Mouth",
            "finding": "No thrush or oral hairy leukoplakia"
          },
          {
            "system": "Lymph nodes",
            "finding": "No enlarged nodes"
          },
          {
            "system": "Skin",
            "finding": "No rash"
          },
          {
            "system": "Neurological",
            "finding": "Grip strength and fine finger movements equal on both sides; no focal deficit"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "HIV infection on antiretroviral therapy",
            "assessment": "Responding well: the viral load has fallen from 186,000 to 42 copies/mL in about 15 weeks and should become undetectable within the next few months, and the CD4 count has risen from 58 to 156. Bictegravir with emtricitabine and tenofovir alafenamide is a recommended first regimen, has a high barrier to resistance, and has no meaningful interaction with aspirin, atorvastatin, ezetimibe, or nitroglycerin. A regimen boosted with ritonavir or cobicistat would raise atorvastatin levels and limit its dose, efavirenz would lower them, and abacavir has been associated with myocardial infarction and should be avoided in a man with coronary disease"
          },
          {
            "problem_id": "PRB-002",
            "display": "Cerebral toxoplasmosis on maintenance therapy",
            "assessment": "Clinically resolved. Trimethoprim-sulfamethoxazole double strength twice daily is an accepted maintenance regimen and also prevents Pneumocystis pneumonia. It can stop once the CD4 count has been above 200 for more than six months on ART with a suppressed viral load, provided he remains free of symptoms. Prophylaxis for Mycobacterium avium complex is not needed, because he started fully active ART promptly"
          },
          {
            "display": "Creatinine",
            "assessment": "The rise from 0.98 to about 1.17 mg/dL is expected and stable. Both bictegravir and trimethoprim block tubular secretion of creatinine without lowering the true filtration rate. Potassium is high-normal on trimethoprim and should be watched"
          },
          {
            "display": "Vaccines",
            "assessment": "Inactivated vaccines can be given at any CD4 count, although responses are better as the count recovers. Live vaccines are contraindicated while the CD4 count is below 200; he is immune to measles, mumps, rubella, and varicella and needs none"
          },
          {
            "problem_id": "PRB-003",
            "display": "Coronary artery disease and HIV",
            "assessment": "HIV raises cardiovascular risk independently, which strengthens rather than changes the secondary-prevention plan: high-intensity atorvastatin with ezetimibe to an LDL below 55 mg/dL, aspirin, and blood pressure below 130/80. Integrase inhibitors can cause weight gain, which should be tracked"
          }
        ],
        "recommendations": [
          "Continue bictegravir, emtricitabine, and tenofovir alafenamide once daily; take it two hours before or six hours after any antacid, calcium, iron, or magnesium",
          "Avoid abacavir, ritonavir- or cobicistat-boosted regimens, and efavirenz; check any new medicine for interactions with the HIV regimen and with atorvastatin",
          "Continue trimethoprim-sulfamethoxazole double strength twice daily; stop it when the CD4 count has been above 200 for more than six months with an undetectable viral load and no symptoms, and restart it if the count falls below 200",
          "No Mycobacterium avium complex prophylaxis",
          "Viral load and CD4 count every three months until the CD4 count is stably above 200 and prophylaxis has stopped, then every three to six months",
          "Blood count, potassium, and creatinine every three months while on trimethoprim-sulfamethoxazole; ALT every six months; lipids per the coronary plan; urine albumin-to-creatinine ratio with the three-month blood tests and then yearly on tenofovir alafenamide, as it was not done at the start of therapy",
          "Second hepatitis B vaccine dose today and a surface antibody check one to two months later; second meningococcal ACWY dose at least eight weeks after the first; recombinant zoster vaccine, two doses; influenza and COVID-19 vaccines each autumn; no live vaccines",
          "Keep atorvastatin 80 mg and the ezetimibe added today, with an LDL goal below 55 mg/dL; track weight on the integrase inhibitor",
          "Anal cancer screening and colorectal cancer screening from age 45, at his preventive visit",
          "Share results with him alone, by secure message, unless he asks otherwise; peer support and counseling are available when he wants them"
        ],
        "communication": "Discussed with Dr. Tolliver, who sees him the same day. The findings and plan were explained to Mr. Ashe, who agreed with them; this report is held in the confidential part of the record, and he received his own copy",
        "follow_up": "Infectious diseases review after the six-month results, or sooner if the viral load is detectable on any check; primary care continues the three-monthly monitoring between visits"
      },
      "guideline_ids": [
        "GL-DHHS-ART",
        "GL-IAS-ART-2024",
        "GL-DHHS-OI",
        "GL-HIVMA-PC-2020",
        "GL-CDC-IMZ-HIV",
        "GL-CCD-2023"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He wants to decide for himself who learns of his HIV diagnosis, and when",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic patient-centered concern echoing his documented choice to keep the diagnosis private at first.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He wants to keep coaching and playing tennis without putting his heart at risk",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "HIV-1 viral load not detected by the three-month visit",
        "status": "completed",
        "target_date": "2026-04-13",
        "outcome": "Viral load not detected (below 20 copies/mL) at three months, and at six and nine months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antiretroviral goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "CD4 count above 200 cells/uL for more than six months with an undetectable viral load, so that maintenance therapy can stop safely",
        "status": "completed",
        "target_date": "2026-10-19",
        "outcome": "CD4 218 at three months, 262 at six months, and 318 at nine months; trimethoprim-sulfamethoxazole stopped",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic immune-recovery goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "LDL cholesterol below 55 mg/dL by the three-month visit",
        "status": "completed",
        "target_date": "2026-04-13",
        "outcome": "LDL cholesterol 52 mg/dL on atorvastatin and ezetimibe",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid goal for very-high-risk coronary disease.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Hepatitis B vaccine series completed with a protective antibody level by the three-month visit",
        "status": "completed",
        "target_date": "2026-04-13",
        "outcome": "Hepatitis B surface antibody 86 mIU/mL",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Keep blood pressure below 130/80 mmHg",
        "status": "completed",
        "target_date": "2026-07-13",
        "outcome": "Blood pressure 116 to 120 over 72 to 74 at every visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Antiretroviral therapy with bictegravir, emtricitabine, and tenofovir alafenamide once daily, chosen for its high barrier to resistance and few interactions with his cardiac medicines; viral load and CD4 count every three months",
        "status": "completed",
        "guideline_ids": [
          "GL-DHHS-ART",
          "GL-IAS-ART-2024",
          "GL-HIVMA-PC-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic antiretroviral plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Infectious diseases consultation to co-manage HIV: the regimen and its interactions, opportunistic-infection prophylaxis, the monitoring schedule, and vaccines",
        "status": "completed",
        "guideline_ids": [
          "GL-DHHS-ART",
          "GL-DHHS-OI"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Toxoplasma maintenance therapy with trimethoprim-sulfamethoxazole double strength twice daily, which also prevents Pneumocystis pneumonia, until the CD4 count is above 200 for more than six months on suppressive therapy; blood count, potassium, and creatinine every three months while on it",
        "status": "completed",
        "guideline_ids": [
          "GL-DHHS-OI"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic opportunistic-infection plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Secondary prevention of coronary disease after two bypass operations: aspirin, high-intensity atorvastatin with ezetimibe added for an LDL goal below 55 mg/dL, blood pressure below 130/80, a heart-healthy diet, regular exercise, and a written chest-pain plan with sublingual nitroglycerin",
        "status": "completed",
        "guideline_ids": [
          "GL-CCD-2023",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic secondary-prevention plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Vaccines for adults with HIV: pneumococcal, hepatitis B with an antibody check afterwards, the two-dose meningococcal ACWY series, recombinant zoster, and seasonal influenza and COVID-19, with no live vaccines while the CD4 count is below 200",
        "status": "completed",
        "guideline_ids": [
          "GL-CDC-IMZ-HIV",
          "GL-HIVMA-PC-2020"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Person-first, confidential care: he decides who learns of his diagnosis; support with disclosure if and when he chooses, peer support, and depression screening with the PHQ-9 at intake and six months and the PHQ-2 at the preventive visit",
        "status": "completed",
        "guideline_ids": [
          "GL-HIVMA-PC-2020",
          "GL-USPSTF-DEP-2023",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-03T17:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-DHHS-ART",
        "title": "Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV",
        "publisher": "U.S. Department of Health and Human Services, Panel on Antiretroviral Guidelines for Adults and Adolescents",
        "url": "https://odphp.health.gov/healthypeople/tools-action/browse-evidence-based-resources/guidelines-use-antiretroviral-agents-adults-and-adolescents-living-hiv",
        "version_or_year": "current online edition"
      },
      {
        "guideline_id": "GL-DHHS-OI",
        "title": "Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV: Toxoplasma gondii encephalitis and Pneumocystis pneumonia sections",
        "publisher": "National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America",
        "url": "https://clinicalinfo.hiv.gov/en/node/9358",
        "version_or_year": "current online edition"
      },
      {
        "guideline_id": "GL-IAS-ART-2024",
        "title": "Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel",
        "publisher": "International Antiviral Society-USA (JAMA)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39616604/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-HIVMA-PC-2020",
        "title": "Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America",
        "publisher": "HIV Medicine Association of the Infectious Diseases Society of America (Clinical Infectious Diseases)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33225349/",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CCD-2023",
        "title": "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease",
        "publisher": "American Heart Association and American College of Cardiology",
        "url": "https://www.ahajournals.org/doi/10.1161/CIR.0000000000001168",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CDC-IMZ-HIV",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, ischemic heart disease and hyperlipidemia monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-PROSTATE-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the choice of TMP-SMX as toxoplasmosis maintenance, the timing of its discontinuation, and the LDL goal."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only what Ashe made public himself and what was reported publicly, from Encyclopedia Virginia, STAT, PBS NewsHour, and Biography.com. The 1976 heart-attack date in one source is recorded as a dispute."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "HIV claims are marked sensitive; the language is person-first; disclosure is his own decision throughout; death recorded without detail."
    }
  }
}
